Form 8-K - Current report:
SEC Accession No. 0001555280-24-000330
Filing Date
2024-11-04
Accepted
2024-11-04 07:04:27
Documents
16
Period of Report
2024-11-04
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K zts-20241104.htm   iXBRL 8-K 32431
2 EX-99.1 exhibit99q32024.htm EX-99.1 855808
7 zoetisca04a01a01a01a01a18a.jpg GRAPHIC 141181
  Complete submission text file 0001555280-24-000330.txt   1265807

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT zts-20241104.xsd EX-101.SCH 2101
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT zts-20241104_def.xml EX-101.DEF 2914
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT zts-20241104_lab.xml EX-101.LAB 23728
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT zts-20241104_pre.xml EX-101.PRE 14206
18 EXTRACTED XBRL INSTANCE DOCUMENT zts-20241104_htm.xml XML 2695
Mailing Address 10 SYLVAN WAY PARSIPPANY NJ 07054
Business Address 10 SYLVAN WAY PARSIPPANY NJ 07054 973-822-7000
Zoetis Inc. (Filer) CIK: 0001555280 (see all company filings)

EIN.: 460696167 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35797 | Film No.: 241420729
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)